Small Molecule Inhibitors of Protein Kinases in Cancer- How to Overcome Resistance

E-ISSN： 1875-5607|6|10|1101-1110

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.6, Iss.10, 2006-10, pp. : 1101-1110

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Small Molecule Aurora Kinases Inhibitors

Current Medicinal Chemistry, Vol. 16, Iss. 16, 2009-06 ,pp. : 1949-1963

Bentham Science Publishers

Access to resources Recommend Favorite

Strategies to Overcome Resistance to Targeted Protein Kinase Inhibitors in the Treatment of Cancer

By Buschbeck Marcus

Drugs in R&D, Vol. 7, Iss. 2, 2006-01 ,pp. : 73-86

Adis International

Access to resources Recommend Favorite

Small-Molecule Inhibitors of Protein-Protein Interactions: How to Mimic a Protein Partner

Current Pharmaceutical Design, Vol. 18, Iss. 30, 2012-10 ,pp. : 4679-4684

Bentham Science Publishers

Access to resources Recommend Favorite

Mechanisms of Clinical Resistance to Small Molecule Tyrosine Kinase Inhibitors Targeting Oncogenic Tyrosine Kinases

By Heiko van der Kuip

American Journal of PharmacoGenomics, Vol. 5, Iss. 2, 2005-01 ,pp. : 101-112

Adis International

Access to resources Recommend Favorite

Small-molecule inhibitors binding to protein kinases. Part I: exceptions from the traditional pharmacophore approach of type I inhibition

By Backes AC Zech B Felber B Klebl B Müller G

Expert Opinion on Drug Discovery, Vol. 3, Iss. 12, 2008-12 ,pp. : 1409-1425

Informa Healthcare

Access to resources Recommend Favorite